The activation of the alternative pathway together with the implication of the MAP3K NIK and their role in cell invasion process are novel findings that we expect opening new therapeutic perspectives for advanced thyroid cancers. This evidence concerns the gene MAP3K14 and thyroid gland carcinoma.